Indraprastha Medical Corporation Ltd
NSE:INDRAMEDCO

Watchlist Manager
Indraprastha Medical Corporation Ltd Logo
Indraprastha Medical Corporation Ltd
NSE:INDRAMEDCO
Watchlist
Price: 385.25 INR -4.91%
Market Cap: ₹35.3B

Balance Sheet

Balance Sheet Decomposition
Indraprastha Medical Corporation Ltd

Balance Sheet
Indraprastha Medical Corporation Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2002 Mar-2003 Mar-2004 Mar-2005 Mar-2006 Mar-2007 Mar-2008 Mar-2009 Mar-2010 Mar-2011 Mar-2012 Mar-2013 Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
56
116
24
63
37
51
21
17
28
8
15
18
20
19
14
19
25
168
203
249
417
523
2 244
3 218
Cash
56
116
24
63
37
51
21
17
28
8
15
18
20
19
14
19
25
168
203
249
417
523
616
615
Cash Equivalents
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1 628
2 603
Short-Term Investments
0
0
0
0
0
13
12
17
15
23
9
9
4
6
7
0
0
0
0
0
0
740
1 603
2 571
Total Receivables
202
273
362
532
791
864
553
568
664
658
872
945
1 044
1 014
1 241
1 184
990
869
911
872
654
750
649
858
Accounts Receivables
70
109
190
262
407
384
161
82
70
325
324
525
644
705
848
983
845
762
792
674
434
682
584
755
Other Receivables
133
164
172
269
385
480
392
486
595
333
548
420
400
309
393
201
145
107
119
198
220
68
65
103
Inventory
45
41
40
83
64
78
95
91
96
97
103
117
124
91
96
100
91
83
121
87
100
85
75
70
Other Current Assets
35
35
35
35
47
63
96
126
104
164
196
232
281
156
164
277
223
235
180
206
403
134
137
198
Total Current Assets
338
465
460
712
939
1 069
777
819
907
950
1 194
1 320
1 473
1 286
1 522
1 579
1 329
1 356
1 415
1 414
1 574
2 231
3 080
4 311
PP&E Net
1 658
1 639
1 588
1 424
1 652
1 692
1 932
2 012
2 091
2 594
2 753
2 997
2 924
3 047
3 018
2 939
2 928
2 809
3 013
2 833
2 752
2 766
3 464
3 600
PP&E Gross
1 658
1 639
1 588
1 424
1 652
1 692
1 932
2 012
2 091
2 594
2 753
2 997
2 924
0
3 018
2 939
2 928
2 809
3 013
2 833
2 752
2 766
3 464
3 600
Accumulated Depreciation
460
561
670
920
1 047
1 163
1 321
1 505
1 669
1 707
1 921
2 039
2 287
0
341
625
903
1 121
1 381
1 620
1 792
2 159
2 128
2 275
Intangible Assets
0
0
9
6
3
3
3
2
4
4
6
6
23
20
19
18
12
4
14
34
17
10
11
6
Note Receivable
0
0
0
0
0
0
0
0
0
7
61
56
67
42
47
45
51
55
48
38
274
63
41
23
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
455
605
549
Other Long-Term Assets
12
9
6
3
0
0
0
10
36
26
7
2
2
3
0
3
3
0
0
0
0
27
32
27
Total Assets
2 009
N/A
2 113
+5%
2 064
-2%
2 145
+4%
2 594
+21%
2 765
+7%
2 712
-2%
2 843
+5%
3 038
+7%
3 581
+18%
4 020
+12%
4 381
+9%
4 488
+2%
4 397
-2%
4 605
+5%
4 584
0%
4 323
-6%
4 224
-2%
4 490
+6%
4 320
-4%
4 617
+7%
5 551
+20%
7 232
+30%
8 516
+18%
Liabilities
Accounts Payable
100
88
43
87
96
92
130
150
247
361
300
380
643
746
885
721
713
910
1 037
918
768
982
1 396
1 225
Accrued Liabilities
3
4
2
2
6
8
8
8
2
29
56
83
61
0
0
0
0
0
0
0
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
150
246
222
150
296
447
648
386
3
40
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
173
148
215
220
150
50
25
60
60
21
25
28
25
17
22
Other Current Liabilities
284
334
428
488
611
713
495
656
821
569
1 013
1 063
845
464
523
463
225
268
298
216
139
290
241
540
Total Current Liabilities
386
426
473
577
713
814
633
814
1 070
1 282
1 763
1 962
1 920
1 655
1 905
1 857
1 384
1 241
1 396
1 159
935
1 296
1 654
1 787
Long-Term Debt
380
360
161
231
497
536
646
493
293
427
279
297
258
107
25
0
210
150
0
0
25
0
323
305
Deferred Income Tax
204
265
316
253
263
280
293
318
318
307
314
338
355
351
343
307
298
274
203
223
232
200
197
154
Other Liabilities
0
0
0
0
0
0
0
0
0
71
72
75
84
90
95
112
108
119
213
210
171
261
281
303
Total Liabilities
970
N/A
1 050
+8%
950
-10%
1 060
+12%
1 473
+39%
1 630
+11%
1 572
-4%
1 625
+3%
1 681
+3%
2 087
+24%
2 427
+16%
2 671
+10%
2 617
-2%
2 203
-16%
2 368
+7%
2 276
-4%
2 000
-12%
1 783
-11%
1 812
+2%
1 592
-12%
1 363
-14%
1 757
+29%
2 455
+40%
2 549
+4%
Equity
Common Stock
917
917
917
917
917
917
917
917
917
917
917
917
917
917
917
917
917
917
917
917
917
917
917
917
Retained Earnings
122
146
197
169
205
218
223
301
440
577
676
793
955
1 277
1 324
1 388
1 400
1 518
1 776
1 800
2 386
3 018
3 983
5 180
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
4
7
5
15
11
48
140
122
130
Total Equity
1 039
N/A
1 063
+2%
1 114
+5%
1 085
-3%
1 121
+3%
1 134
+1%
1 140
+0%
1 218
+7%
1 357
+11%
1 493
+10%
1 593
+7%
1 710
+7%
1 871
+9%
2 194
+17%
2 238
+2%
2 308
+3%
2 323
+1%
2 440
+5%
2 678
+10%
2 728
+2%
3 254
+19%
3 795
+17%
4 778
+26%
5 967
+25%
Total Liabilities & Equity
2 009
N/A
2 113
+5%
2 064
-2%
2 145
+4%
2 594
+21%
2 765
+7%
2 712
-2%
2 843
+5%
3 038
+7%
3 581
+18%
4 020
+12%
4 381
+9%
4 488
+2%
4 397
-2%
4 605
+5%
4 584
0%
4 323
-6%
4 224
-2%
4 490
+6%
4 320
-4%
4 617
+7%
5 551
+20%
7 232
+30%
8 516
+18%
Shares Outstanding
Common Shares Outstanding
92
92
92
92
92
92
92
92
92
92
92
92
92
92
92
92
92
92
92
92
92
92
92
92
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett